Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase. While momentum can be a leading indicator, it has burned many investors as it doesn’t always correlate with long-term success. On that note, here is one stock with lasting competitive advantages and two best left ignored. Two Momentum Stocks to Sell: Health Catalyst (HCAT) One-Month Return: +8.6% Founded by healthcare professionals Tom Burton and Steve Barlow in 2008, Health Catalyst (NASDAQ:HCAT) provides data and analytics technology to healthcare organizations, enabling them to improve care and lower costs. Why Are We Cautious About HCAT? Muted 7% annual revenue growth over the last three years shows its demand lagged behind its software peers Gross margin of 45.9% reflects its high servicing costs Competitive market means the company must spend more on sales and marketing to stand out even if the return on investment is low Health Catalyst’s stock price of $4.17 implies a valuation ratio of 0.8x forward price-to-sales. Check out our free in-depth research report to learn more about why HCAT doesn’t pass our bar. Peloton (PTON) One-Month Return: +7.5% Started as a Kickstarter campaign, Peloton (NASDAQ: PTON) is a fitness technology company known for its at-home exercise equipment and interactive online workout classes. Why Do We Steer Clear of PTON? Number of connected fitness subscribers has disappointed over the past two years, indicating weak demand for its offerings Sales are projected to tank by 5.1% over the next 12 months as its demand continues evaporating Poor expense management has led to operating losses At $6.13 per share, Peloton trades at 7.3x forward EV-to-EBITDA. Dive into our free research report to see why there are better opportunities than PTON. One Momentum Stock to Buy: Magnite (MGNI) One-Month Return: +60% Born from the 2020 merger of Rubicon Project and Telaria, Magnite (NASDAQ:MGNI) operates the world's largest independent sell-side advertising platform that automates the buying and selling of digital advertising inventory across all channels and formats. Why Should You Buy MGNI? Annual revenue growth of 33.3% over the last five years was superb and indicates its market share increased during this cycle Impressive free cash flow profitability enables the company to fund new investments or reward investors with share buybacks/dividends, and its growing cash flow gives it even more resources to deploy Rising returns on capital show the company is starting to reap the benefits of its past investments Story Continues Magnite is trading at $15.49 per share, or 16.9x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free. Stocks We Like Even More Market indices reached historic highs following Donald Trump’s presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth. While this has caused many investors to adopt a "fearful" wait-and-see approach, we’re leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 176% over the last five years. Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today for free. View Comments
1 Mooning Stock Worth Your Attention and 2 to Avoid
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...